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Abstract 
A new computational method ̶ the multiple moving plug (MMP) model ̶ is described to simulate the effect 
of gastrointestinal motility and dissolution on the pharmacokinetic profile of any given drug. The method is 
physiologically more consistent with the experimental evidence that fluid exists in discrete plugs in the 
gastrointestinal tract, and therefore is more realistic than modeling the gastrointestinal tract as a series of 
compartments with first-order transfer. The number of plugs used in simulations, their gastric emptying 
times and volumes, and their residence times in the small intestine can be matched with experimental 
data on motility. In sample simulations, drug absorption from a series of fluid plugs emptied from the 
stomach at evenly spaced time intervals showed lower Cmax and higher Tmax than an equivalent dose 
emptied immediately as a single plug. To the extent that new techniques can establish typical ranges for 
the volumes of fluid emptied from the stomach and their respective timing, the MMP model may be able 
to predict the effect of gastric emptying on the variability seen in pharmacokinetic profiles. This could lead 
to an expanded safe space for the regulatory acceptance of formulations based on dissolution data. 
©2020 by the authors. This article is an open-access article distributed under the terms and conditions of the Creative Commons 
Attribution license (http://creativecommons.org/licenses/by/4.0/). 
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Introduction 
Several reports have expressed the view that gastrointestinal (GI) transit is more realistically modeled 
as discrete plugs of fluid emptying from the stomach and moving through the small intestine rather than as 
a first-order process between static compartments [1-3]. Experimental evidence comes from magnetic 
resonance imaging showing isolated pockets of fluid in the GI tract [4-6]. Two of the reports [1,2] describe 
stochastic models for gastric emptying, but these models omit the effects of drug dissolution, absorption, 
and metabolism on plasma drug concentrations. By contrast, the multiple moving plug (MMP) model [3] is 
a natural extension of a well-established dissolution model [7-9], the default model in GastroPlus [10], and 
can simulate the effects of both the gastric emptying of plugs and the dissolution within the plugs on 
plasma drug concentrations. The MMP model is capable of utilizing either experimental data or stochastic 
simulations of the volumes and timing of plugs emptying from the stomach. The computational method of 
the MMP model is described here in more rigorous mathematical detail than previously discussed [3]. 
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Sample simulations show the effects of gastric emptying on the pharmacokinetics of a hypothetical drug. 
Computational method 
A system of coupled differential equations describing drug dissolution, absorption, and metabolism was 
solved numerically using the fourth-order Runge-Kutta method. Development of this system has been 
described previously as well as the derivation of the Noyes-Whitney equation assuming spherical drug 
particle geometry [3,7,8]. The equations used are summarized in Table 1 including the definitions of 
variables and parameters. New is the addition of the index j  to create and track discrete plugs that move 
independently through the GI tract as illustrated in Figure 1. It should be noted that Figure 1 was drawn to 
show a reasonably realistic length-to-diameter ratio for the small intestine and was untangled to facilitate 
this perspective [11]. In reality, the small intestine must be much more convoluted to fit into the small 
space of the abdominal cavity. Independence is achieved by making plug-specific initial conditions and 
time-/position-dependent changes to variables associated with each plug. Increasing the number of plugs 
allows more refined simulation of localized GI events and the resulting variability in drug plasma 
concentrations. A specific example of the Microsoft Visual Basic code used for the simulations is available 
at https://intellipharm.com/wp-content/uploads/2020/04/mmp.txt. Reference 3 provides a general 
explanation of the coding techniques applied to the MMP model. 
 
Figure 1. Drawing of the GI tract illustrating multiple moving plugs of fluid. In the simulations for Figures 2-4, 
the first plug (j=1) to empty from the stomach at time zero is shown in red, the second (j=2) at 15 minutes is 
shown in blue, and the third (j=3) at 30 minutes is shown in green. 
 
A step size of 0.001 minute was used for the Runge-Kutta method. The iterative nature of this method 
allows any parameter to be changed at a frequency equal to the step size. Equations 1-4 describe how drug 
mass changes in various locations, but other parameters can be changed to match the physical 
characteristics of the location. For example, it has already been described how hij changes with a change in 
drug particle radius as particles dissolve [3,7,8]. Because the number of parameter changes that could be 
simulated is unlimited, only kaj was altered to explore the potential effect of gastric emptying on the drug 
plasma concentration profile. Table 2 lists the other parameters used in the simulations that were held 
constant. They are similar to the values reported for nifedipine [12]. 
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Table 1. Differential equations and symbol definitions for the multiple moving plug model. 
quantity being tracked equation 
solid drug mass (mg) in the GI tract in plug j from 
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cl clearance (mL/min or mL/min/mg) 
Csj time-dependent drug solubility (mg/mL) for drug in plug j 
D drug diffusion coefficient (cm2/min) 
Fj bioavailability factor for presystemic metabolism in plug j  
hij 
time-dependent diffusion layer thickness (cm) for particles in plug j from particle size 
fraction i 
kaj  time-dependent absorption rate constant for plug j 
k12 rate constant for transfer of drug from the plasma to the tissue compartment 
k21 rate constant for transfer of drug from the tissue to the plasma compartment 
mb body mass when Vd is given in units of volume per unit of body mass 
n number of drug particle size fractions 
np number of plugs 
ρ drug density (mg/cm3) 
io
r  initial particle radius (cm) for particles in particle size fraction i 
t time (min) 
Vd volume of distribution (mL or mL/mg) 
Vj time-dependent volume (mL) of plug j 
Xoij initial solid drug mass (mg) in the GI tract in plug j from particle size fraction i 
 
In keeping with the generally accepted view that the main site of drug absorption is the small intestine 
and not the stomach [13], kaj was assumed to be zero while plug j was in the stomach. The number of plugs 
exiting the stomach could be any number np, and the volume of each plug Vj could be any fraction of the 
total volume containing any fraction of the total dose. For simplicity, each Vj was equal to 240 mL divided 
by np (240 mL/3 = 80 mL). 
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Table 2. Parameters used for simulations. 
To simulate gastric emptying, kaj was transitioned from its 
value of zero in the stomach to its value of 0.07 min-1 in the 
duodenum. The transition time was assumed to be 1 minute. 
Table 3 shows the equation and parameters used to simulate a 
smooth sigmoidal transition for the value of kaj, but any 
appropriate function could be used to accomplish the 
transition. A simulation using immediate changes for kaj instead 
of smooth transitions was essentially the same as the original 
simulation. However, smooth transitions are recommended as abrupt changes can lead to instabilities in 
the numerical method. 
Table 3. Equation and symbol definitions used to simulate a smooth transition for the absorption rate constant. 
quantity being tracked equation 
Time dependent absorption 
rate constant for plug j 2 2
a si a stj j j j j j
j j
a si a stj j









symbol  definition 
kajsi absorption rate constant for plug j in the small intestine 
kajst  absorption rate constant for plug j in the stomach 
tkajsi time at which kaj completes its transition to kajsi from kajst  
tkajst  time at which kaj begins its transition from kajst to kajsi 
The function described by Equation 8 in Table 3 is bounded by two pair of points: (tkajst, kajst) and   (tkajsi, 
kajsi). The number of transitions can be increased by using Equation 8 and common points as the start and 
end points of transitions. The time course of transitions taking place within a given plug can be made to be 
completely independent of that in any other plug. If the initial conditions and transitions that define each 
plug are exactly the same, then the simulation would be equivalent to a single plug of the equivalent total 
dose and volume. 
Modeled as a series of discrete fluid plugs exiting the stomach, each containing drug particles in the 
process of dissolving, the effect of gastric emptying and drug particle size on drug pharmacokinetics was 
simulated for three evenly-spaced plugs. The total dose and fluid volume were held constant, but the drug 
particle size and dose in individual plugs were changed between simulations as shown in Table 4. In each 
simulation, the first plug began to transition from the stomach to the small intestine immediately, the 
second beginning at 15 minutes, and the third beginning at 30 minutes. 
Table 4. Plug specific parameters used in Figure 2-4 simulations. 
Figure plug # 
gastric emptying 
onset time (min) 
dose in plug 
(mg) 
drug particle size 
(µm) 
2 
1 0 (red) 0.8 1 
2 15 (blue) 0.8 1 
3 30 (green) 0.8 1 
3 
1 0 (red) 0.8 10 
2 15 (blue) 0.8 10 
3 30 (green) 0.8 10 
4 
1 0 (red) 0 1 
2 15 (blue) 1.2 1 
3 30 (green) 1.2 1 
parameter value 
drug solubility (mg/mL) 0.01 







body mass (kg) 70 
bioavailability factor 0.5 
clearance (mL/min/kg) 4 
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Results and Discussion 
Figures 2-4 show a series of simulations using the multiple moving plug model. The main goal was to 
provide a visual and conceptual understanding of the model and its capabilities within a limited number of 
simulations. With this in mind, the number of plugs (3), their individual volumes (80 mL), and the timing of 
their gastric emptying (0, 15, and 30 min) were held constant. The spacing of plug emptying times was 
intentionally exaggerated to allow visual distinction between the plugs. To make more accurate 
simulations, the number, volumes, and emptying times of plugs should be selected to agree with emerging 
experimental measurements. Figures 2-4 show the individual plasma compartment drug concentrations 
arising from drug absorption from individual plugs as well as the total drug concentration from all plugs. 
The solid lines represent plasma concentrations using the left axis and dashed lines represent absorption 
rate constants using the right axis. For the absorption rate constant versus time profiles, the sigmoidal 
shape of the transition representing gastric emptying is difficult to discern, but it should be noted that it is 
not an abrupt change. 
In Figure 2, the concentration profiles from individual plugs appear to have the same shape. This is 
because dissolution is essentially complete for all plugs when they are simulated to empty from the 
stomach. In comparison, the individual profiles in Figure 3 are clearly different due to the slower 
dissolution rate from larger drug particles. In Figure 3, the first plug (red) has significantly less drug 
dissolved than the last plug (green) when they empty from the stomach. This results in a slower rate of 
drug absorption from the first plug compared to the last plug and illustrates the ability of the MMP model 
to model plugs independently. 
Figure 4 illustrates the ability of the MMP model to simulate inhomogeneity in the stomach by assigning 
different initial conditions to various plugs. The situation depicted in Figure 4 might arise if a dosage form 
does not disintegrate immediately after ingestion with water. In this case, the first plug of fluid to empty 
from the stomach does not contain any drug. Instead, the 0.8 mg of drug in the first plug in Figure 2 was 
divided evenly between the second and third plugs. As expected, there was a delay in the onset of drug 
absorption in Figure 4 relative to Figure 2. The simulation in Figure 4 also resulted in a higher Cmax for the 
total drug concentration compared to Figure 2. 
 
Figure 2. Simulated plasma drug concentration (left axis) from 3 individual plugs (red, blue, and green solid 
lines) as well as the summation of all plugs (black solid line). Absorption from individual plugs begins at the 
onset of the absorption rate constant transitioning from 0 to 0.07 min
-1
 shown as dashed lines and scaled 
using the right axis. Table 4 lists figure specific simulation parameters. 
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Figure 3. Simulated plasma drug concentration (left axis) from 3 individual plugs (red, blue, and green solid 
lines) as well as the summation of all plugs (black solid line). Absorption from individual plugs begins at the 
onset of the absorption rate constant transitioning from 0 to 0.07 min
-1
 shown as dashed lines and scaled 
using the right axis. Table 4 lists figure specific simulation parameters. Figure 3 uses a larger drug particle size 
compared to Figure 2. 
Figure 5 compares the summation plasma concentration profiles in Figures 2-4 as well as a new 
simulation for absorption of the same total dose from a single plug to serve as a reference point. In 
general, simulating gastric emptying as a sequential movement of a series of independent plugs of fluid 
from the stomach to the intestine resulted in a reduced Cmax and increased Tmax compared to a single plug. 
 
Figure 4. Simulated plasma drug concentration (left axis) from 3 individual plugs (red, blue, and green solid 
lines) as well as the summation of all plugs (black solid line). Absorption from individual plugs begins at the 
onset of the absorption rate constant transitioning from 0 to 0.07 min
-1
 shown as dashed lines and scaled 
using the right axis. Table 4 lists figure specific simulation parameters. Figure 4 removes the amount of drug in 
the first plug and splits it evenly between the second and third plugs compared to Figure 2. 
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Figure 5. Simulated plasma drug concentration (summation only) from Figure 2 (gray line), Figure 3 (dashed 
line), and Figure 4 (solid thinner line) compared to a one-plug simulation for reference (solid heavier line) that 
emptied from the stomach using the absorption rate constant transition for the first plug in Figures 2-4. 
The MMP model invokes the need for real time data on the number, timing, and volume of fluid plugs 
emptying from the stomach and moving through the intestine. Schiller et al. [6] reported a mean small 
intestinal fluid volume of 105 mL contained in a mean number of separated fluid pockets of 4. However, 
this assessment was a one-time observation made 1 hour after the last dose in a sequence of non-
disintegrating marker capsules was given in the fasting state. Mudie et al. [4] tracked the number, volume, 
and approximate location of fluid packets at fixed time points. After dosing 240 mL of water in the fasted 
state, the number of small intestinal water pockets increased from about 8 initially to about 16 before 
decreasing gradually over the 2-hour time period studied. The mean volume of the pockets was in the 3-7 
mL range. Mudie et al. [4] acknowledge that it is possible that a significant portion of the dose could be 
confined to just a few pockets. This suggests that the focus should be on the fluid that is likely to contain 
drug at the time of dosing and on its movement thereafter. 
It may also be possible to group fluid that empties from the stomach over a certain time range to 
reduce the number of fluid plugs while retaining the characteristics of the MMP model. The advantage in 
doing so is to reduce the computational time required to run a simulation. The same strategy has been 
applied successfully for simulating the dissolution of polydisperse drug powders by grouping drug particles 
within a certain size range into a single size group that is representative of the range. Figure 6 compares 
the simulation in Figure 2 with a simulation where the only differences are an increase in the number of 
plugs from 3 to 7 and a decrease in the dose in each plug from one third of the total dose to one seventh. 
The total plasma concentration profiles from the two simulations were not substantially different, 
indicating that there is potential to reduce the number of plugs without changing the simulation 
significantly. The number of plugs used in the MMP should be no more than the number observed 
experimentally and potentially only a fraction thereof. 
The summation technique of the MMP model is similar to the superposition principle, except that the 
summation occurs at each step of the numerical method, as opposed to summing the contributions after 
all plugs have been simulated. This treatment allows the MMP model to handle non-linear 
pharmacokinetics. Different metabolic rates can be tied to the continuously updated drug mass in different 
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locations: the intestine for gut wall metabolism, the portal vein for first-pass hepatic metabolism, or the 
plasma compartment for renal clearance. The pharmacokinetic model described in Table 1 would have to 
be expanded to allow for the simulation of portal vein drug concentrations. 
 
Figure 6. Simulated plasma drug concentration from Figure 2 (red) compared to a new simulation (black) 
except that the new simulation used 7 plugs instead of 3, and the total dose was divided evenly between 7 
plugs instead of 3. The heavier lines represent summations from the lighter individual plug lines. 
The advantage of the MMP model is that it provides a more realistic computational approach to 
simulating gastric emptying and GI motility compared to the advanced compartmental absorption and 
transit (ACAT) model. Historically, the ACAT model has assumed that both solid and dissolved drug move 
from compartment to compartment in a first-order process without any concomitant movement of 
compartmental fluid, which remains static in terms of both position and volume [14]. These assumptions 
are inconsistent with physical observations and cannot be replicated experimentally. Indeed, the 
development of dissolution testing apparatus involving more than one dissolution vessels to mimic the 
stomach and segments of the small intestine rely on the concomitant movement of water and solid and 
dissolved drug [15]. Ehrlein and Schemann [16] have created a website with links to videos using 
fluoroscopy that provide visual confirmation of the true nature of GI motility. 
The other advantage of the MMP model is that all processes are modeled from the perspective of 
isolated plugs of moving fluid, making experimental validation of the model components possible. For 
example, it has already been mentioned that the dissolution component of the MMP model has been 
established [7,8] and independently verified [9] for a constant volume of fluid. However, in vivo, the 
volume of the dissolution fluid will change; increasing due to secretion of fluids or decreasing due to water 
absorption. Testing of the dissolution model to simulate secretion can be accomplished by adding fluid to 
the dissolution vessel at a known rate. On the other hand, removing fluid to simulate water absorption is 
more difficult. Evaporation is probably not fast enough to mimic the rate of water absorption from the GI 
tract, but could be used to test the dissolution model over a narrow range. There is no reason to believe 
that the principles of the mechanistic dissolution model should fail in extrapolating to higher rates of water 
removal. Moreover, there is a need to simulate the effect of water absorption on drug dissolution and 
absorption as the reduction in water volume in the GI tract after dosing has been clearly shown by Mudie 
et al. [4] In either case, water secretion or absorption, the volume change in a dissolution vessel can be 
measured and corrected at each step of the numerical simulation. The dissolution fluid could also be 
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titrated with physiological buffers, dynamically adjusting the pH-dependent solubility and volume change 
simultaneously. 
The MMP model is completely flexible; any number of plugs containing dissolving drug can empty from 
the stomach, each having a volume and emptying time to match experimental measurements. The critical 
physiological parameters are the volume of the plugs, the timing of their emptying, and their residence 
time in various segments of the intestinal tract. Regional differences in permeability and intestinal wall 
metabolism can be adjusted to reflect the current position of individual plugs. Although the simulations 
shown in Figures 2-4 were run with equally spaced plugs of the same volume to demonstrate the model, 
using real gastric emptying data will enable more accurate simulations.  
The MMP model assumes that suspended and dissolved drug are homogeneously mixed within the 
plug, and that only dissolved drug can leave the plug through permeation of the intestinal membrane. 
There is no mass transfer between plugs, but plugs could be made to converge or diverge by manipulating 
the time-dependent parameters. It would also be possible to break up a large volume of fluid into several 
smaller plugs in order to simulate a stepwise concentration gradient axially from the leading to the trailing 
end of the plug series. 
It has long been recognized that gastric emptying can affect the rate of drug absorption [17,18]. This 
rate, characterized by Cmax and Tmax, is used to establish bioequivalence when considering a formulation 
change or when comparing a generic dosage form to an innovator’s product. Simulations show that Cmax 
and Tmax are sensitive to gastric emptying as modeled by the MMP model. If the bioequivalence criteria are 
too tight, a dosage form could fail bioequivalence testing due to physiological factors beyond the control of 
the formulation. To address this problem, Dickinson et al. [19] have discussed the concept of a safe space 
to allow for the effect of physiological factors like gastric emptying on the bioequivalence criteria. 
Physiologically based pharmacokinetic (PBPK) modeling holds promise for establishing this safe space and 
for providing confidence in making predictions. The hope is that a simple dissolution test could serve to 
establish bioequivalence in conjunction with PBPK modeling. The theoretical advantage of the MMP model 
lies in its mechanistically-based mathematical integration of dissolution, gastric emptying, and intestinal 
motility in a way that is closer to how these processes occur in the GI tract. 
Conclusions 
In conclusion, the MMP model provides a more mechanistically realistic computational tool to study the 
effects of dissolution, gastric emptying, and intestinal motility on the drug plasma concentration profile. 
The ability to establish the impact of dissolution and GI motility on bioequivalence criteria may expand safe 
space for regulatory approval of pharmaceutical products based on limited dissolution data and 
mechanistically-based simulations. 
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